MedTech Acquisition Corporation
NASDAQ: MTAC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Christopher C. Dewey
- Headquarters
- Greenwich, United States
- IPO year
- 2021
- Market cap
- $83.9M
Loading MTAC…
Loading profile data…Frequently asked questions about MTAC
What does MedTech Acquisition Corporation (MTAC) do?
MedTech Acquisition Corporation currently has no significant active business operations. The firm's stated intention is to pursue and finalize a business combination — which could involve a merger, stock exchange, asset acquisition, or other forms of corporate restructuring — with one or more enterprises in the U.S. healthcare industry. Establis...
Where does MTAC trade?
MedTech Acquisition Corporation (MTAC) trades on the NASDAQ Capital Market.
What sector is MTAC in?
MedTech Acquisition Corporation (MTAC) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of MedTech Acquisition Corporation?
Christopher C. Dewey is the chief executive officer of MedTech Acquisition Corporation (MTAC).
Where is MedTech Acquisition Corporation headquartered?
MedTech Acquisition Corporation is headquartered in United States.
Does MTAC pay a dividend?
MedTech Acquisition Corporation (MTAC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MTAC go public?
MedTech Acquisition Corporation (MTAC) completed its initial public offering in 2021.